Skip to main content
. 2003 Dec;93(12):2046–2049. doi: 10.2105/ajph.93.12.2046

TABLE 2—

Vaccine Coverage Levels Among American Indian/Alaska Native (AIAN) Children Aged 19–35 Months, by Selected Vaccines: National Immunization Survey, 1998–2000a

10 Statesb AI/AN % (95% CI) 10 Statesb Non-AI/AN % (95% CI) US AI/AN % (95% CI) US Non-AI/AN % (95% CI)
DTP/DT/DtaP
    ≥ 3 doses 94.2 (90.7, 97.8) 93.7 (93.0, 94.4) 92.7 (88.7, 96.6) 95.2 (94.9, 95.5)
    ≥ 4 doses 84.4 (80.0, 88.7) 80.2 (79.1, 81.3) 79.1 (74.2, 83.9) 83.0 (82.6, 83.5)
Poliovirus
    ≥ 3 doses 90.2 (86.3, 94.1) 88.8 (87.9, 89.6) 87.7 (83.4, 92.0) 90.0 (89.6, 90.4)
Haemophilus influenzae type b
    ≥ 3 doses 91.5 (87.6, 95.4) 91.7 (90.9, 92.4) 90.5 (86.4, 94.6) 93.5 (93.2, 93.8)
MCV
    ≥ 1 dose 90.4 (86.4, 94.4) 89.2 (88.3, 90.0) 90.0 (86.7, 93.3) 91.5 (91.1, 91.8)
Hepatitis B
    ≥ 3 doses 87.0 (82.8, 91.2) 86.0 (85.0, 86.9) 86.0 (81.4, 90.5) 88.5 (88.1, 88.9)
Varicellac
    ≥ 1 dose 46.6 (41.2, 51.9) 49.7 (48.4, 51.0) 48.5 (43.3, 53.7) 58.2 (57.6, 58.8)
Combined series
    4:3:1:3d 78.2 (73.4, 83.0) 75.1 (73.9, 76.3) 74.0 (69.0, 79.0) 78.0 (77.5, 78.5)

Note. CI = confidence interval; DTP = diphtheria and tetanus toxoids and pertussis vaccine; DT = diphtheria and tetanus toxoids; DtaP = diphtheria and tetanus toxoids and acellular pertussis vaccine; MCV = measles-containing vaccine.

aChildren in survey period born between February 1995 and May 1999.

bAlaska, Arizona, Montana, Nevada, New Mexico, North Dakota, Oklahoma, South Dakota, Washington, and Wyoming.

cSignificant difference between US AIAN and US non-AIAN.

dFour or more doses of diphtheria and tetanus toxoids and pertussis vaccine, 3 or more doses of poliovirus vaccine, 1 or more doses of measles-containing vaccine, and 3 or more doses of Haemophilus influenzae type b vaccine.